bromocriptine has been researched along with curcumin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliveri, V | 1 |
| Chellappan, DK; Collet, TA; Dighe, SN; Dua, K; Ekwudu, O; Katavic, PL | 1 |
| Chen, S; Kansra, S; Miller, M; Woodliff, J | 1 |
| Asadi, H; Mansoori, A; Movafagh, A; Sadeghizadeh, M; Shahraeini, SS; Sheikhpour, M; Yazdian, F | 1 |
| Cai, X; Ma, C; Tang, C; Yang, J; Yuan, F; Zhu, J | 1 |
2 review(s) available for bromocriptine and curcumin
| Article | Year |
|---|---|
Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation.
Topics: alpha-Synuclein; Amyloidogenic Proteins; Drug Discovery; Humans; Protein Aggregation, Pathological; Structure-Activity Relationship | 2019 |
Recent update on anti-dengue drug discovery.
Topics: Animals; Antiviral Agents; Biological Products; Cell Line, Tumor; Dengue Virus; Drug Discovery; Humans; Serine Proteinase Inhibitors; Viral Nonstructural Proteins; Virus Replication | 2019 |
3 other study(ies) available for bromocriptine and curcumin
| Article | Year |
|---|---|
Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bromocriptine; Cell Proliferation; Clone Cells; Curcumin; Cyclin D3; Cyclins; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Phosphorylation; Pituitary Hormones; Pituitary Neoplasms; Prolactinoma; Rats; Retinoblastoma Protein; Time Factors; Tumor Cells, Cultured | 2008 |
Co-Administration of Curcumin and Bromocriptine Nano-liposomes for Induction of Apoptosis in Lung Cancer Cells
Topics: Apoptosis; Bromocriptine; Cell Line, Tumor; Cell Survival; Curcumin; Drug Delivery Systems; Drug Liberation; Humans; Liposomes; Lung Neoplasms; Nanoparticles; Particle Size | 2020 |
Curcumin Sensitizes Prolactinoma Cells to Bromocriptine by Activating the ERK/EGR1 and Inhibiting the AKT/GSK-3β Signaling Pathway In Vitro and In Vivo.
Topics: Animals; Apoptosis; Bromocriptine; Cell Cycle; Cell Line, Tumor; Curcumin; Dopamine Agonists; Glycogen Synthase Kinase 3 beta; Mice; Pituitary Neoplasms; Prolactinoma; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2021 |